Le Lézard
Classified in: Health, Science and technology, Covid-19 virus
Subjects: Conference, Webcast

Arcturus Therapeutics to Attend Upcoming Investor Conferences


Arcturus Therapeutics Holdings Inc. (the "Company", "Arcturus", Nasdaq: ARCT), a commercial messenger RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases, today announced that the Company will participate in the following investor conferences:

Piper Sandler 36th Annual Healthcare Conference (Fireside Chat)

Citi's 2024 Global Healthcare Conference (Attending)

7th Annual Evercore HealthCONx Conference (Fireside Chat)

Webcast links can be found under Investor Relations/Events section of Arcturus' website.

About Arcturus

Founded in 2013 and based in San Diego, California, Arcturus Therapeutics Holdings Inc. (Nasdaq: ARCT) is a commercial mRNA medicines and vaccines company with enabling technologies: (i) LUNAR® lipid-mediated delivery, (ii) STARR® mRNA Technology (sa-mRNA) and (iii) mRNA drug substance along with drug product manufacturing expertise. Arcturus developed KOSTAIVE®, the first self-amplifying messenger RNA (sa-mRNA) COVID vaccine in the world to be approved. Arcturus has an ongoing global collaboration for innovative mRNA vaccines with CSL Seqirus, and a joint venture in Japan, ARCALIS, focused on the manufacture of mRNA vaccines and therapeutics. Arcturus' pipeline includes RNA therapeutic candidates to potentially treat ornithine transcarbamylase (OTC) deficiency and cystic fibrosis (CF), along with its partnered mRNA vaccine programs for SARS-CoV-2 (COVID-19) and influenza. Arcturus' versatile RNA therapeutics platforms can be applied toward multiple types of nucleic acid medicines including messenger RNA, small interfering RNA, circular RNA, antisense RNA, self-amplifying RNA, DNA, and gene editing therapeutics. Arcturus' technologies are covered by its extensive patent portfolio (over 400 patents and patent applications in the U.S., Europe, Japan, China, and other countries). For more information, visit www.ArcturusRx.com. In addition, please connect with us on Twitter and LinkedIn.


These press releases may also interest you

at 16:38
Federal government invests in greener public transit across Quebec
The federal government is investing over $400 million in 11 infrastructure projects, including three in Montréal, to make public transit greener across Quebec. First, more than $200.5 million will be used to electrify the St-Laurent ($106.7 million)...

at 12:25
ViewLift Powers New ROOT SPORTS Stream App for Seattle Mariners
ViewLift, a global leader in end-to-end streaming technology, today announced the launch of the new ROOT SPORTS Stream app, delivering Seattle Mariners games and ROOT SPORTS programming directly to fans across the Pacific Northwest?with or without a...

at 12:00
Nature Cell's JointStem Becomes the First Korean Company to Acquire Breakthrough Therapy Designation from the U.S. FDA
-The first Korean company granted Breakthrough Therapy Designation (BTD) from the U.S. FDA-Clinical trials and results from a three-year follow-up show significant improvements compared to existing treatments-The BTD designation, achieved following...

at 10:14
Xinhua Silk Road: Parallel Forum on Inclusive Finance and Approaches to New Energy Industrialization Development held in Beijing
The Parallel Forum on Inclusive Finance and Approaches to New Energy Industrialization Development was held in Beijing on March 20. As a side event of the 2025 Global South Financiers Forum, the forum, hosted by the Brand Work Office of Xinhua News...

at 09:03
Prime Biome Alerts Consumers About Misleading Third-Party Resellers and Reinforces Commitment to Product Integrity
The official brand behind Prime Biome has issued a public advisory regarding unauthorized third-party resellers misrepresenting the product online. Reports of unverified vendors listing non-official versions of Prime Biome across various platforms...

at 08:56
ProDentim Alerts Consumers About Misleading Third-Party Resellers and Reinforces Commitment to Product Integrity
The official brand behind ProDentim has issued a public advisory regarding unauthorized third-party resellers misrepresenting the product online. Reports of unverified vendors listing non-official versions of ProDentim across various platforms have...

More news about Science and technology...


News published on and distributed by: